Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience-Reference-Cited by-同舟云学术

Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience

Published:2021-10-14 Issue:2 Volume:29 Page:791-801
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Carr Michael J.,Sun James,DePalo Danielle,Rothermel Luke D.,Song Yun,Straker Richard J.,Baecher Kristin,Louie Raphael J.,Stahlie Emma H. A.,Wright G. Paul,Naqvi Syeda Mahrukh Hussnain,Kim Youngchul,Sarnaik Amod A.,Karakousis Giorgos C.,Lowe Michael C.,Delman Keith A.,van Akkooi Alexander C. J.,Ollila David W.,Collichio Frances,Zager Jonathan S.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-021-10910-5.pdf

Reference22 articles.

1. Thompson JF, Mozzillo N, Ross MI, et al. Local melanoma recurrence, satellitosis, and in-transit metastasis: incidence, outcomes, and selection of treatment options. In: CM Balch, MB Atkins, C Garbe, et al., editors. Cutaneous melanoma. Cham: Springer; 2020. p. 867–94.

2. Andtbacka RH, Kaufman HL, Collichio F, et al. Talimogene laherparepvec improves durable response rate in patients with advanced melanoma. J Clin Oncol. 2015;33(25):2780–8.

3. Perez MC, Miura JT, Naqvi SMH, et al. Talimogene laherparepvec (TVEC) for the treatment of advanced melanoma: a single-institution experience. Ann Surg Oncol. 2018;25(13):3960–5.

4. Perez MC, Zager JS, Amatruda T, et al. Observational study of talimogene laherparepvec use for melanoma in clinical practice in the United States (COSMUS-1). Melanoma Manag. 2019;6(2):MMT19.

5. Louie RJ, Perez MC, Jajja MR, et al. Real-world outcomes of talimogene laherparepvec therapy: a multi-institutional experience. J Am Coll Surg. 2019;228(4):644–9.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of intramuscular melanoma metastases to the psoas;BMJ Case Reports;2024-06

2. Intralesional and Infusional Updates for Metastatic Melanoma;Cancers;2024-05-22

3. First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0;Molecular Cancer Therapeutics;2024-04-24

4. Beyond the Scalpel: Advancing Strategic Approaches and Targeted Therapies in Nonexcisable Melanomas;Journal of Skin Cancer;2024-01

5. Viral Immunotherapy Strategies in Clinical Practice;The Basics of Cancer Immunotherapy;2024